Profile
We are early stage investors focused on the future of ophthalmology & life sciences.
Working collaboratively with investors, OpthaFund selects the top companies in the industry in order to support and guide strategic investments. With a diversified investment portfolio, OphthaFund has already led numerous successful investments through funding rounds for innovators within the Ophthalmology industry.
Industry
Region of investment
OphthaFund Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
ForwardVue Pharma
|
Venture Capital (VC)
|
Biotechnology
|
Seed
Series A
|
North America
|
$5-10 m
|
$1 M
|
August 2020
|
|
Allysta Pharmaceuticals
|
Venture Capital (VC)
|
Biotechnology
Pharmaceuticals
|
Series A
|
North America
|
$5-10 m
|
$20 M
|
November 2022
|
Contacts
Upgrade to see contacts
Name
Title
Email
Social Networks
If there are no contacts of this investor, please write to us, we will try to find them as
soon as possible and get back
to you!
FAQs about OphthaFund
Where is OphthaFund located?
OphthaFund is located in Charleston, South Carolina, United States.
When was OphthaFund founded?
OphthaFund was founded in 2019.
What sectors and industries does OphthaFund invest in?
OphthaFund invests in companies and startups in Biotechnology, Healthcare Services, Medical Devices, Pharmaceuticals, MedTech, Life Sciences, HealthTech.
What is OphthaFund geographical focus of investments?
OphthaFund invests in companies and startups in North America.
At what stages of companies and startups does OphthaFund typically invest in?
OphthaFund invests in companies and startups at Seed, Series A.
What is the usual amount of OphthaFund investment?
OphthaFund usually invests $10-50 m on average.
What is the amount of assets of under management (AUM) for OphthaFund?
OphthaFund has around $30m assets under management.
When was OphthaFund last fund created?
OphthaFund last fund was created/launched in 2022-11-08